Filing Details
- Accession Number:
- 0001209191-20-049886
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-09 19:17:17
- Reporting Period:
- 2020-09-08
- Accepted Time:
- 2020-09-09 19:17:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1496323 | Igm Biosciences Inc. | IGMS | Pharmaceutical Preparations (2834) | 770349194 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1787681 | Shinyu Daniel Chen | C/O Igm Biosciences, Inc. 325 E. Middlefield Road Mountain View CA 94043 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-09-08 | 602 | $50.20 | 116,518 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
Billionaire Hedge Funds
